Form 4: Dexcom Director Karen M Dahut Transfers Shares to Trust
SEC Form 4 Filing
Director Karen M Dahut transferred shares of Dexcom Inc. from direct ownership to a trust, according to a recent SEC Form 4 filing.
Summary
- On May 18, 2024, Karen M Dahut, a director of Dexcom Inc., transferred 2,906 shares of Dexcom common stock from direct ownership to the WILLIAM L DAHUT, JR TRUST & KAREN M DAHUT TRUST.
- The transfer occurred upon the vesting of previously awarded restricted stock units.
- Following the transaction, Ms. Dahut directly owns 0 shares and indirectly owns 15,166 shares through the trust.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing detailing a share transfer to a trust, which is neutral in sentiment.
Industry Context
This is a routine disclosure related to insider transactions and doesn't necessarily reflect a change in the company's fundamentals or outlook.
Key Dates
| Date | Description |
|---|---|
| 06/14/2005 | Date of the WILLIAM L DAHUT, JR TRUST & KAREN M DAHUT TRUST |
| 05/18/2024 | Date of share transfer from direct ownership to trust |
| 05/21/2024 | Date of signature on the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.